Skip to main content

Perspectives on Some Recent Studies on RAMPs

  • Chapter
RAMPs

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 744))

  • 1011 Accesses

Abstract

This book on RAMPs covers a number of aspects on the biology of RAMPs. However, due to the uniqueness of some recent studies, they were not covered under a general title. Therefore, in this chapter, we describe three recent studies wherein RAMPs were found to be important players in cancer, hypertension and asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brekhman V, Lugassie J, Zaffryar-Eilot S et al. Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2. FASEB J 2011; 25(1):55–65.

    Article  PubMed  CAS  Google Scholar 

  2. Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci 2006; 63(19–20):2304–2316.

    Article  PubMed  CAS  Google Scholar 

  3. Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 2003; 88(4):660–672.

    Article  PubMed  CAS  Google Scholar 

  4. Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 2001; 70:1–32.

    Article  PubMed  CAS  Google Scholar 

  5. Baker AM, Cox TR, Bird D et al. The role of Lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. J Natl Cancer Inst 2011; 103(5):407–424.

    Article  PubMed  CAS  Google Scholar 

  6. Barker HE, Chang J, Cox TR et al. LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res 2011; 71(5):1561–1572.

    Article  PubMed  CAS  Google Scholar 

  7. Wilgus ML, Borczuk AC, Stoopler M et al. Lysyl oxidase: A lung adenocarcinoma biomarker of invasion and survival. Cancer 2010.

    Google Scholar 

  8. Santhanam AN, Baker AR, Hegamyer G et al. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene 2010; 29(27):3921–3932.

    Article  PubMed  CAS  Google Scholar 

  9. Schietke R, Warnecke C, Wacker I et al. The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J Biol Chem 2010; 285(9):6658–6669.

    Article  PubMed  CAS  Google Scholar 

  10. Payne SL, Fogelgren B, Hess AR et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 2005; 65(24):11429–11436.

    Article  PubMed  CAS  Google Scholar 

  11. Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D et al. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J 2005; 24(19):3446–3458.

    Article  PubMed  CAS  Google Scholar 

  12. Perl AK, Wilgenbus P, Dahl U et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392(6672):190–193.

    Article  PubMed  CAS  Google Scholar 

  13. Li T, Li D, Cheng L et al. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma. Ann Surg Oncol 2010; 17(7):1937–1944.

    Article  PubMed  Google Scholar 

  14. Chrissobolis S, Zhang Z, Kinzenbaw DA et al. Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction. Stroke 2010; 41(10):2329–2334.

    Article  PubMed  CAS  Google Scholar 

  15. Sabharwal R, Zhang Z, Lu Y et al. Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension. Hypertension 2010; 55(3):627–635.

    Article  PubMed  CAS  Google Scholar 

  16. Petersen KA, Birk S, Lassen LH et al. The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 2005; 25(2):139–147.

    Article  PubMed  CAS  Google Scholar 

  17. Gangula PR, Supowit SC, Wimalawansa SJ et al. Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy. Hypertension 1997; 29(1 Pt 2):248–253.

    PubMed  CAS  Google Scholar 

  18. Supowit SC, Zhao H, Hallman DM et al. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat. Hypertension 1997; 29(4):945–950.

    PubMed  CAS  Google Scholar 

  19. Supowit SC, Zhao H, Hallman DM et al. Calcitonin gene-related peptide is a depressor in subtotal nephrectomy hypertension. Hypertension 1998; 31(1 Pt 2):391–396.

    PubMed  CAS  Google Scholar 

  20. Li J, Wang DH. Development of angiotensin II-induced hypertension: role of CGRP and its receptor. J Hypertens 2005; 23(1):113–118.

    Article  PubMed  CAS  Google Scholar 

  21. Zhang Z, Winborn CS, Marquez de Prado B et al. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 2007; 27(10):2693–2703.

    Article  PubMed  CAS  Google Scholar 

  22. Bonner K, Kariyawasam HH, Ali FR et al. Expression of functional receptor activity modifying protein 1 by airway epithelial cells with dysregulation in asthma. J Allergy Clin Immunol 2010; 126(6):1277–1283, e1273.

    Article  PubMed  CAS  Google Scholar 

  23. Kay AB, Ali FR, Heaney LG et al. Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics. Allergy 2007; 62(5):495–503.

    Article  PubMed  CAS  Google Scholar 

  24. Wu H, Guan C, Qin X et al. Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation. Pulm Pharmacol Ther 2007; 20(5):513–524.

    Article  PubMed  CAS  Google Scholar 

  25. Larson SD, Plopper CG, Baker G et al. Proximal airway mucous cells of ovalbumin-sensitized and-challenged Brown Norway rats accumulate the neuropeptide calcitonin gene-related peptide. Am J Physiol Lung Cell Mol Physiol 2004; 287(2):L286–L295.

    Article  PubMed  CAS  Google Scholar 

  26. Aoki-Nagase T, Nagase T, Oh-Hashi Y et al. Attenuation of antigen-induced airway hyperresponsiveness in CGRP-deficient mice. Am J Physiol Lung Cell Mol Physiol 2002; 283(5):L963–L970.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Narayanan Parameswaran .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Landes Bioscience and Springer Science+Business Media

About this chapter

Cite this chapter

Parameswaran, N., Spielman, W.S. (2012). Perspectives on Some Recent Studies on RAMPs. In: Spielman, W.S., Parameswaran, N. (eds) RAMPs. Advances in Experimental Medicine and Biology, vol 744. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2364-5_9

Download citation

Publish with us

Policies and ethics